Open-label duloxetine treatment of major depression in patients age ≥ 65

被引：0
|
作者：
Kennedy, JS [1 ]
Mallinckrodt, CH [1 ]
Wohlreich, MM [1 ]
Raskin, J [1 ]
Goldstein, DJ [1 ]
Tran, PV [1 ]
Detke, M [1 ]
机构：
[1] Lilly Corp Ctr, Indianapolis, IN USA
来源：
JOURNAL OF CLINICAL PSYCHIATRY | 2002年 / 63卷 / 11期
关键词：
D O I：
暂无
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
收藏
页码：1069 / 1069
页数：1
相关论文
共 50 条
  • [21] Mirtazapine in the treatment of adolescents with major depression: An open-label, multicenter pilot study
    Haapasalo-Pesu, KM
    Vuola, T
    Lahelma, L
    Marttunen, M
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2004, 14 (02) : 175 - 184
  • [22] Comparing duloxetine and pregabalin for treatment of pain and depression in women with fibromyalgia: an open-label randomized clinical trial
    Bidari, Ali
    Moazen-Zadeh, Ehsan
    Ghavidel-Parsa, Banafsheh
    Rahmani, Shahrzad
    Hosseini, Sajjad
    Hassankhani, Amir
    DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 27 (01) : 149 - 158
  • [23] Comparing duloxetine and pregabalin for treatment of pain and depression in women with fibromyalgia: an open-label randomized clinical trial
    Ali Bidari
    Ehsan Moazen-Zadeh
    Banafsheh Ghavidel-Parsa
    Shahrzad Rahmani
    Sajjad Hosseini
    Amir Hassankhani
    DARU Journal of Pharmaceutical Sciences, 2019, 27 : 149 - 158
  • [24] An open-label, controlled study of citalopram versus moclobemide in patients with major depression
    de Alba, LC
    de Oca, RMM
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1998, 59 (02): : 107 - 115
  • [25] An Open-Label Pilot Study of Duloxetine in Patients With Irritable Bowel Syndrome and Comorbid Major Depressive Disorder
    Lewis-Fernandez, Roberto
    Lam, Peter
    Lucak, Susan
    Galfalvy, Hanga
    Jackson, Elizabeth
    Fried, Jane
    Rosario, Melissa
    de la Cruz, Ana Alicia
    Sanchez-Lacay, Arturo
    Diaz, Samantha
    Schneier, Franklin
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2016, 36 (06) : 710 - 715
  • [26] Open-Label Study of Duloxetine for the Treatment of Obsessive-Compulsive Disorder
    Dougherty, Darin D.
    Corse, Andrew K.
    Chou, Tina
    Duffy, Amanda
    Arulpragasam, Amanda R.
    Deckersbach, Thilo
    Jenike, Michael A.
    Keuthen, Nancy J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2015, 18 (02): : 1 - 4
  • [27] Duloxetine in the treatment of irritable bowel syndrome: an open-label pilot study
    Brennan, Brian P.
    Fogarty, Kate V.
    Roberts, Jacqueline L.
    Reynolds, Karina A.
    Pope, Harrison G., Jr.
    Hudson, James I.
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2009, 24 (05) : 423 - 428
  • [28] TMS in the acute treatment of major depression: Clinical response in an open-label extension trial
    Avery, David
    Isenberg, Keith E.
    Sampson, Shirlene
    Janicak, Philip G.
    Lisanby, Sarah
    Maixner, Daniel
    Loo, Colleen
    Demitrack, Mark
    George, Mark
    BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 174S - 174S
  • [29] Venlafaxine in treatment-resistant major depression: A Canadian multicenter, open-label trial
    de Montigny, C
    Silverstone, PH
    Debonnel, G
    Blier, P
    Bakish, D
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1999, 19 (05) : 401 - 406
  • [30] Mirtazapine in treatment of adolescents with major depression. An open-label, multicenter pilot study
    Haapasalo-Pesu, KM
    Vuola, T
    Lahdelma, L
    Marttunen, M
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S198 - S198
12345